Aarey Drugs & Pharmaceuticals Ltd. - Research Center
524412 AREYDRG Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 21 | Mar ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | |
|---|---|---|---|---|---|
| Sales | 232.17 | 170.33 | 129.76 | 138.99 | 142.95 |
| Operating profit | 6.35 | 0.82 | 2.38 | 3.42 | 3.37 |
| Interest | 1.08 | 0.87 | 0.88 | 0.59 | 0.63 |
| Gross profit | 6.75 | 4.21 | 3.92 | 4.61 | 3.91 |
| EPS (Rs) | 2.29 | 1.03 | 1.45 | 1.82 | 1.77 |
Half yearly
results in details
| Sep ' 21 | Mar ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | |
|---|---|---|---|---|---|
| Other income | 1.49 | 4.26 | 2.43 | 1.79 | 1.17 |
| Stock adjustment | 3.42 | - | - | - | - |
| Raw material | 218.81 | 165.60 | 124.58 | 133.36 | 137.92 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.23 | - | 0.12 | - | - |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | 2.22 | 1.66 |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 3.36 | 3.91 | 2.67 | - | - |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.90 | 0.37 | 0.53 | 0.36 | 0.35 |
| Taxation | 0.50 | 1.45 | - | - | - |
| Net profit / loss | 5.35 | 2.40 | 3.40 | 4.25 | 3.56 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 23.38 | 23.38 | 23.39 | 23.38 | 20.08 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | 200.85 |
| Agg.of non promotoholding (%) | - | - | - | - | 100.00 |
| OPM (%) | 2.73 | 0.48 | 1.83 | 2.46 | 2.36 |
| GPM (%) | 2.89 | 2.41 | 2.97 | 3.28 | 2.71 |
| NPM (%) | 2.29 | 1.37 | 2.57 | 3.02 | 2.47 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis